JSR Life Sciences

Executive Summary

JSR Life Sciences is a Belgium-based contract research and manufacturing organization (CRO/CDMO) dedicated to advancing cell and gene therapies. Through its subsidiaries, Crown Bioscience and KBI Biopharma, and its proprietary bioprocessing products, the company provides integrated services from early-stage discovery to commercialization. Founded in 2017, JSR Life Sciences capitalizes on the growing demand for outsourced manufacturing in the cell and gene therapy space. With a focus on next-generation medicines, the company is well-positioned to benefit from increasing R&D investments and regulatory approvals in the sector. While privately held, JSR Life Sciences demonstrates strong operational synergies and a comprehensive service offering that differentiates it in a competitive landscape.

Upcoming Catalysts (preview)

• Q3 2026Capacity expansion at KBI Biopharma facilities80% success
• Q4 2026Strategic partnership for cell therapy manufacturing60% success
• Q3 2026FDA approval of a client's gene therapy product manufactured by JSR50% success